- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 14/52 - CytokinesLymphokinesInterférons
Détention brevets de la classe C07K 14/52
Brevets de cette classe: 1712
Historique des publications depuis 10 ans
|
113
|
125
|
131
|
147
|
149
|
129
|
136
|
124
|
101
|
62
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 4701 |
26 |
| The Regents of the University of California | 20745 |
24 |
| Yale University | 2533 |
23 |
| The Trustees of the University of Pennsylvania | 4415 |
19 |
| The Board of Trustees of the Leland Stanford Junior University | 6653 |
18 |
| Vib VZW | 905 |
18 |
| The General Hospital Corporation | 4870 |
14 |
| Memorial Sloan-Kettering Cancer Center | 2043 |
14 |
| Universiteit Gent | 1404 |
14 |
| Genentech, Inc. | 4104 |
13 |
| Institute for Research in Biomedicine (IRB) | 42 |
13 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3304 |
13 |
| Arla Foods amba | 556 |
11 |
| Chugai Seiyaku Kabushiki Kaisha | 1423 |
11 |
| The United States Government AS represented by The Department of Veterans Affairs | 1329 |
11 |
| Washington University | 1737 |
11 |
| Immunitybio, Inc. | 507 |
11 |
| Ith Immune Therapy Holdings | 15 |
11 |
| Akamis bio, Inc. | 32 |
11 |
| Centre National de La Recherche Scientifique | 11023 |
10 |
| Autres propriétaires | 1416 |